Apply to trial NCT07556484

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 1Drug trial

Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

The purpose of this study is to determine the 72-hour pharmacokinetics of emulsified avacopan at a dose of 30 mg twice daily given to up to 6 patients with active severe GPA or MPA with diffuse alveolar hemorrhage (DAH) requiring mechanical ventilation for respiratory support.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening